Against the backdrop of the epidemic raging around the world, the COVID-19 vaccine is regarded as the savior, bringing hope to the end of the epidemic. Therefore, in this year, pharmaceutical companies all over the world raced against the clock to solve the problem of vaccine research and development. Finally, vaccines from Russia, the US, Germany, the UK and China were successively approved to be marketed.
So what happens when the vaccine comes out?
This article takes you to find out.
More than 40 countries start to vaccinate against COVID-19!
How’s it going?
On August 11, Russian President Vladimir Putin announced that SputnikV, the world’s first COVID-19 vaccine, had been registered, making Russia the first country in the world to do so.
But the SputnikV is a “premature” vaccine that has yet to complete the most critical phase III clinical trial, which is crucial for vaccine development because only large human trials can detect unusual side effects.
But the fighting nations are fierce, to which The Russians responded by taking a “watch as you use” approach in the third phase of the test.
As of December 10, more than 150,000 people in Russia had been vaccinated against SputnikV, Russian media reported.
The country has also received orders for 1.2 billion doses of vaccine from more than 50 countries.
On December 2nd Britain approved the use of a COVID-19 vaccine jointly developed by Pfizer of the United States and BioNTech of Germany.
Then the NATIONAL Health Service (NHS) said two of its staff had an allergic reaction after being vaccinated against Pfizer.
On December 30th Britain became the first country in the world to approve a COVID-19 vaccine developed by Oxford University and Astrazeneca.
More than 600,000 people in the UK are currently vaccinated.
On December 10, the US Food and Drug Administration (FDA) officially gave Pfizer the “green light” for the vaccine.
On December 19th the FDA gave Modena the go-ahead again.
But as the epidemic in the United States accelerated, the number of people in the United States who received their first dose of vaccine was 2.794 million as of December 30, according to the Centers for Disease Control and Prevention, well below the country’s earlier goal of 20 million vaccinations by 2021.
More than 40 countries, including Russia, the United Kingdom, the United States, Turkey, the United Arab Emirates, Argentina, Canada, France, Germany and Israel, have started to receive the COVID-19 vaccine, and India plans to do so in 2021.
Free vaccination for all Chinese people!
A total of 4.5 million doses were administered
On December 31, Sinopac China BiocoVID-19 inactivated vaccine has been approved by the State Food and Drug Administration to be listed with conditions.
As early as December 9, the COVID-19 vaccine developed by Sinopac was registered and marketed in the United Arab Emirates. Phase III clinical data of the country showed that the effective rate of the Chinese vaccine was 86%.
Meanwhile, Turkey also announced that the effectiveness of COVID-19 vaccine from Sinovac was 91.25%.
Egypt said earlier that the effectiveness of the COVID-19 vaccine delivered by Sinopac reached 86 percent.
Brazil also claims that Sinovac’s Kelaofu vaccine is the safest COVID-19 vaccine on the market.
It is worth mentioning that On December 31, Zeng Yixin, head of the vaccine research and development section of the Joint Prevention and Control Mechanism under The State Council, said that vaccines will be provided free of charge to all people in China.
We should know that vaccine research and development is a big project that costs human, material and financial resources. Only after a series of experiments can we get this hard-won result.
This New Year’s gift, benefiting 1.4 billion people, is truly remarkable.
So what about vaccination in China?
China has received more than 3 million doses of the vaccine since it was officially launched on December 15, according to officials. The results fully demonstrate the safety of the vaccine, with less than 0.1 percent of cases suffering from mild fever.
From July to the end of November this year, relevant Chinese authorities have completed 1.5 million doses of emergency inoculation of China’s inactivated vaccine against high-risk groups in China.
About 60,000 of them went abroad to work in high-risk areas. After strict monitoring and follow-up observation of adverse reactions, no serious adverse reactions or cases of severe infection were reported.